Basic Information
ID: ALA4145136
Type: Binding
Description: Inhibition of protease L10F/V32I/M46I/I47V/Q58E/I84V mutant in HIV1 A17 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay
Format: BAO_0000219
Organism: Human immunodeficiency virus 1
Strain: A17
Target: Protease(ALA2366517)
Document: ALA4138310
Inhibition of protease L10F/V32I/M46I/I47V/Q58E/I84V mutant in HIV1 A17 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4145136
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 628.81 | 4.33 | 4.33 |
| 575.73 | 3.71 | 3.71 |
| 726.90 | 4.27 | 4.27 |
| 808.01 | 5.03 | 5.03 |
| 743.88 | 3.12 | 3.12 |
| 698.89 | 4.89 | 4.89 |
| 724.88 | 3.16 | 3.16 |
| 713.86 | 3.11 | 3.11 |
| 728.91 | 4.90 | 4.90 |
| 759.97 | 3.35 | 3.35 |
| 756.92 | 4.28 | 4.28 |